Apollo launches platelet donor community for dengue patients

Apollo Hospitals, in association with Godrej's Hit spray, on Tuesday, launched India's first online "platelet donor community" for patients suffering from dengue. The dengue virus reduces patients’ count of platelets -- tiny blood cells that help the body form clots to stop bleeding.

In India, dengue has emerged as one of the biggest threats to public health. The reported dengue cases in the country increased four times in the last six years from 28,292 in 2010 to 1, 29,166 in 2016, with 245 deaths in 2016.

"This is a significant initiative for the country as the viral disease has emerged as a dangerous threat to the public. Through this initiative, we are trying to bridge the disparity in awareness and provide ready resources to manage dengue," Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, told the media.

"Dengue has emerged as a serious threat to public health in India. While people are aware that mosquito bites cause dengue, they are unaware of the curative measures, especially about platelets," added Sunil Kataria, Business Head (India and SAARC), Godrej Consumer Products (GCPL).

If the platelet count drops below 20,000, the patient has higher chances of developing bleeding as well as brain haemorrhage, leading to death. Thus, a speedy platelet transfusion is necessary to save the life of the patient.

"Unlike blood, which is donated once in three months or once in a year, platelets can be donated by a healthy individual every three days, as the body has the ability to regenerate it," Reddy said.